首頁 > 市場調查報告書 > 醫療設備

生技設備

微生物檢測市場規模、佔有率和成長分析（按檢測類型、產品類型、技術、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1950918

微生物檢測市場規模、佔有率和成長分析（按檢測類型、產品類型、技術、應用、最終用戶和地區分類）－2026-2033年產業預測

Microbiology Testing Market Size, Share, and Growth Analysis, By Test Type (Culture, Molecular), By Product (Instruments & Equipment, Reagents & Consumables), By Technology, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月20日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球微生物檢測市場規模將達到 56.3 億美元，到 2025 年將成長至 61.4 億美元，到 2033 年將成長至 123.2 億美元，在預測期（2026-2033 年）內，複合年成長率為 9.09%。

全球微生物檢測產業涵蓋多種調查方法，利用各種平台和自動化系統進行微生物鑑定，應用於醫療保健、食品安全和藥品品管。其重要性源於日益成長的健康需求、頻繁爆發的感染疾病以及將診斷檢測準確性與患者預後和產品安全緊密聯繫起來的嚴格監管標準。市場正從傳統的培養和顯微鏡檢查轉向快速分子診斷和次世代定序，這主要受對更快檢測結果和更高靈敏度的需求所驅動，尤其體現在PCR技術在病原體檢測中的廣泛應用。這種發展趨勢推動了對整合儀器的投資增加，並促進了對高通量、多重檢測的需求成長，從而能夠加快治療速度，並滿足藥品和食品生產中嚴格的監管要求，最終改善公眾健康狀況。

微生物檢測市場按多個維度進行細分，包括檢測類型、產品類型、技術、應用、最終用戶和地區。檢測類型包括培養檢測、分子檢測、免疫分析、生化檢測和抗菌藥物敏感性試驗。產品類型包括儀器設備、試劑和耗材以及軟體和服務。技術包括基於培養的檢測、分子診斷、質譜分析、快速和自動化方法以及生物感測器和奈米技術檢測。應用包括臨床診斷、環境檢測、食品飲料檢測、藥物檢測和工業品管。最終用戶包括醫院、診斷檢查室、製藥和生物技術公司、食品飲料公司、學術和研究機構、環境檢測機構以及化妝品和個人護理實驗室。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球微生物檢測市場成長要素

快速診斷檢測在臨床和非臨床領域的日益普及，顯著推動了全球微生物檢測市場的成長。這些檢測能夠快速出結果，使醫療機構能夠儘早啟動治療，因此需要開發更多可靠的微生物檢測產品。此外，分散式檢查系統的趨勢也促使製造商創新研發更緊湊、更易於使用的平台，從而提升了檢測產品的可及性，使其能夠惠及更廣泛的消費者群體。醫療機構正轉向先進的微生物檢測解決方案，以建立高效的患者管理系統，確保流暢的患者照護流程，這也推動了市場的持續擴張。

限制全球微生物檢測市場的因素

全球微生物檢測市場面臨許多限制因素，其中最主要的是先進微生物平台的高昂部署和維修成本。這些經濟負擔對預算有限的小規模實驗室和舊有系統影響尤為顯著，阻礙了新技術的應用。高昂的初始成本加上持續的試劑費用，使得機構不願意從需要大量投資才能升級的舊有系統遷移，儘管這些系統仍然能夠提供臨床益處。預算限制迫使機構優先考慮某些檢測服務，從而限制了供應商拓展市場佔有率的機會。此外，買家日益增強的成本意識也抑制了他們的購買行為，最終阻礙了整體市場的成長。

全球微生物檢測市場趨勢

全球微生物檢測市場正呈現出將數位診斷技術與先進資訊系統融合的顯著趨勢。這項發展催生了新的微生物調查方法，這些方法利用檢查室資訊系統和雲端分析來簡化操作並最佳化決策流程。遠端監控功能的引入提高了檢測效能追蹤和自動化資料管理能力，而人工智慧驅動的分析則確保了偵測結果的一致性。供應商和軟體開發商之間的合作正在推動以樣本追蹤和品管為重點的綜合承包解決方案的出現，從而促進了可擴展檢查室網路的構建，實現了無縫數據共用並提供即時臨床洞察。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific
Merck KGaA
Becton Dickinson and Company
bioMerieux
Abbott Laboratories
Danaher Corporation
Roche Diagnostics
Agilent Technologies
Qiagen NV
Hologic Inc.
Lonza Group AG
Siemens Healthineers AG
Luminex Corporation
PerkinElmer, Inc.
Genomatix Software GmbH
Charles River Laboratories
Sartorius AG
Greiner Bio-One International GmbH
Bio-Rad Laboratories, Inc.
MilliporeSigma

結論與建議

簡介目錄

Product Code: SQMIG35H2409

Global Microbiology Testing Market size was valued at USD 5.63 Billion in 2024 and is poised to grow from USD 6.14 Billion in 2025 to USD 12.32 Billion by 2033, growing at a CAGR of 9.09% during the forecast period (2026-2033).

The global microbiology testing sector encompasses various diagnostic methodologies that leverage diverse platforms and automated systems for microbial identification in healthcare, food safety, and pharmaceutical quality control. Its significance has escalated due to rising health demands, frequent infectious disease outbreaks, and stringent regulatory standards that connect the accuracy of diagnostic tests to patient outcomes and product safety. The market is transitioning from traditional culturing and microscopy to rapid molecular diagnostics and next-generation sequencing, driven by the need for faster results and enhanced sensitivity, particularly evident through the widespread adoption of PCR for pathogen detection. This evolution has prompted increased investments in integrated instruments, while the demand for high-throughput and multiplexed assays grows, enabling quicker treatments and compliance with rigorous regulatory requirements in pharmaceuticals and food manufacturing, ultimately improving public health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbiology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbiology Testing Market Segments Analysis

The microbiology testing market is categorized across multiple dimensions, including test type, product, technology, application, end user, and region. By test type, the market comprises culture testing, molecular testing, immunological testing, biochemical testing, and antibiotic susceptibility testing. By product, it is divided into instruments & equipment, reagents & consumables, and software & services. By technology, the market includes culture-based testing,molecular diagnostics, mass spectrometry, rapid or automated methods, and biosensors & nano-based assays. By application, microbiology testing is used in clinical diagnostics, environmental testing, food & beverage testing, pharmaceutical testing, and industrial quality control. By end user, the market serves hospitals, diagnostic laboratories,pharmaceutical & biotechnology companies, food & beverage companies, academic & research institutes, environmental testing laboratories, and cosmetics & personal-care laboratories. Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Microbiology Testing Market

The increasing adoption of rapid diagnostic tests across medical and non-medical settings significantly fuels growth in the Global Microbiology Testing market. These tests provide quick results, allowing healthcare providers to initiate treatment sooner and necessitating the development of additional reliable microbiology testing products. Additionally, the trend toward decentralized testing systems compels manufacturers to innovate more compact and user-friendly platforms, enhancing accessibility for a wider range of consumers. Healthcare facilities are focusing on advanced microbiology testing solutions to establish efficient patient management systems, ensuring a smooth patient care process, which in turn drives ongoing expansion within the market.

Restraints in the Global Microbiology Testing Market

The Global Microbiology Testing market faces significant constraints due to the high acquisition and maintenance costs associated with advanced microbiology platforms. These financial burdens particularly impact smaller laboratories and facilities with limited budgets, hindering their ability to adopt new technologies. The combination of substantial upfront expenses and ongoing reagent costs discourages organizations from transitioning away from legacy systems, which, despite requiring considerable investment for upgrades, still offer clinical benefits. Budget limitations compel organizations to prioritize certain testing services over others, restricting vendors' opportunities to broaden their market presence. Additionally, heightened cost sensitivity among purchasers curtails their purchasing behavior, consequently impeding overall market growth.

Market Trends of the Global Microbiology Testing Market

The Global Microbiology Testing market is experiencing a significant trend towards the integration of digital diagnostic technologies with advanced informatics systems. This evolution is leading to new microbiology testing methodologies that leverage laboratory information systems and cloud-based analytics to streamline operations and enhance decision-making processes. The implementation of remote monitoring capabilities allows for improved assay performance tracking and automatic data management, facilitated by AI-driven analysis that ensures consistency in testing outcomes. Collaborations between vendors and software developers are resulting in comprehensive, turnkey solutions focused on sample tracking and quality control, which in turn fosters the creation of scalable laboratory networks, promoting seamless data sharing and real-time clinical insights.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index, 2025
PESTEL Analysis
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape
Technology Assessment

Global Microbiology Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Culture Testing
Molecular Testing
Immunological Testing
Biochemical Testing
Antibiotic Susceptibility Testing

Global Microbiology Testing Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments & Equipment
Reagents & Consumables
Software & Services

Global Microbiology Testing Market Size by Technology & CAGR (2026-2033)

Market Overview
Culture-based Testing
Molecular Diagnostics
Mass Spectrometry
Rapid/Automated Methods
Biosensors & Nano-based Assays

Global Microbiology Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Clinical Diagnostics
Environmental Testing
Food & Beverage Testing
Pharmaceutical Testing
Industrial Quality Control

Global Microbiology Testing Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Laboratories
Pharmaceutical & Biotech Companies
Food & Beverage Companies
Academic & Research Institutes
Environmental Testing Labs
Cosmetics & Personal-Care Labs

Global Microbiology Testing Market Size & CAGR (2026-2033)

North America (Test Type, Product, Technology, Application, End User)
- US
- Canada
Europe (Test Type, Product, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Product, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Product, Technology, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Product, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genomatix Software GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Greiner Bio-One International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MilliporeSigma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments